Published in Women's Health Weekly, July 17th, 1995
Bernadete Nonnenmacher et al. used an ELISA to assess antivirion immune responses in a case-control study in Columbia and Spain ("Serologic Response to Human Papillomavirus Type 16 (HPV-16) Virus-Like Particles in HPV-16 DNA-Positive Invasive Cervical Cancer and Cervical Intraepithelial Neoplasia Grade III Patients and Controls...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly